Investigators: Helen Leonard, Jenny Bourke, Jenny Downs, Peter Richmond
Project description
This study is a clinical trial being conducted across Australia that is looking at whether a new drug can improve function and cognition in people with Down syndrome. At our site in WA we had 26 potential participants who were screened for current medical conditions and their ability to complete the required tests. There were 17 who were found eligible to be in the study and were randomised to either the drug or a placebo. The participants were required to take their medication for 12 weeks and attend 6 visits where medical assessments and other cognitive testing was undertaken. All participants have now completed the study and the final study report is pending.